Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Atlantic Healthcare Names US Management

Executive Summary

Atlantic Healthcare plc. has named the management team which will lead its newly established US commercial and business development operations, based in North Carolina. The specialty pharma company, which focuses on gastrointestinal disorders, has appointed Sireesh Appajosyula vice president (VP) product commercialisation, Jonathan Drutz VP corporate and business development and Jordan Zwick director of corporate and business development. Appajosyula joins Atlantic from Salix Pharmaceuticals, where he led the company’s inflammatory bowel disease division. Drutz has been involved in a variety of life science ventures, acting as a business development executive, investor and consultant. Zwick most recently led business development and corporate strategy at Chimerix, having previously been at Salix and Medtronic.

You may also be interested in...



AstraZeneca And Galapagos Shine At The 15th Annual Scrip Awards

The pharma, biotech and allied industries came together in London on 4 December to celebrate another year of achievement at the 15th Annual Scrip Awards, hosted by the broadcaster Fiona Bruce.

Publisher's Spotlight: Scrip Awards Announces 2019 Finalists

We are delighted to announce the shortlist for the 15th Annual Scrip Awards.

Juvenescence Raises $100M To Advance Anti-Aging Programs

The financing, which brings the total raised by Juvenescence to $165m, comes as longevity R&D programs supported by the company move towards human testing.

Topics

UsernamePublicRestriction

Register

SC065336

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel